Free Trial

Cogent Biosciences (COGT) SEC Filings & 10K Form

Cogent Biosciences logo
$7.14 -0.15 (-2.06%)
Closing price 04:00 PM Eastern
Extended Trading
$7.14 0.00 (0.00%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cogent Biosciences SEC Filings

DateFilerForm TypeView
02/28/2025
7:00 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:20 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
Form SCHEDULE 13G/A
01/22/2025
8:50 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:02 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SCHEDULE 13D/A
01/17/2025
1:05 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:16 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
1:58 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
11:10 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4/A
12/06/2024
11:11 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
12/06/2024
11:12 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4/A
12/06/2024
11:13 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4/A
12/04/2024
1:33 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:35 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:37 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:49 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2024
4:15 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
Form SC 13D/A
12/02/2024
5:40 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 424B5
12/02/2024
5:03 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:32 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
11/15/2024
3:30 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:36 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
1:26 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
11:15 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form EFFECT
08/27/2024
8:00 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/26/2024
4:18 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
08/23/2024
3:35 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
08/23/2024
3:36 PM
Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Form SC 13D/A
08/21/2024
1:24 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:59 AM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:01 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:03 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:04 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
11:20 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q/A
08/19/2024
4:13 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:27 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:01 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form NT 10-Q
07/22/2024
3:52 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
07/17/2024
5:20 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:00 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
11:40 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
🚨This Week: The Political Fallout from Nvidia’s AI Conference (Ad)

Something big is happening TWO days from now on March 20th — and the political world isn’t ready for it. Nvidia is poised to unveil a groundbreaking AI breakthrough, and the implications could shake Washington, Wall Street, and Main Street alike. While the media focuses on tariff chaos and global conflicts, no one is paying attention to the AI revolution that could shift economic power overnight THIS THURSDAY.

Click here now to see how this tech shift could redefine America’s future — and your financial desti
07/08/2024
2:49 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
2:51 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
11:15 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:06 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:10 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:13 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
9:15 AM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
7:53 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:54 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:55 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:56 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
07/01/2024
7:45 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4/A
06/18/2024
3:43 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
11:14 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEFA14A
06/07/2024
10:35 AM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:27 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form DEF 14A
05/30/2024
3:45 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
05/23/2024
4:19 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form PRE 14A
05/20/2024
4:28 PM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
Form SC 13D/A
05/16/2024
7:02 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
11:21 AM
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
Form SC 13D/A
05/16/2024
11:22 AM
Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Form SC 13D/A
05/15/2024
8:55 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:30 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:50 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
4:22 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
4:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form ARS
04/02/2024
3:21 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
4:18 PM
Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
5:01 PM
Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:57 PM
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners